For patients with IIH, sustainable weight loss offers the most effective and lasting relief from symptoms—and can help ...

Hypertension is a leading modifiable risk factor for morbidity and mortality.1–3 While differences in diagnostic cut-off points exist in guidelines,4 5 blood pressure above optimal levels is lineally ...

Pirtobrutinib (Jaypirca) led to improvements in progression-free survival (PFS) and time to next treatment (TTNT) with a favorable tolerability profile when compared with idelalisib (Zydelig) and ...